Health Innovation Manchester (HInM) has published its Impact Report for 2022-2023.
The report details how HInM has delivered against all its key commissions from NHS England and the Office of Life Sciences through 2022/23.
Key highlights in the report include:
- Strong delivery against all national AHSN requirements across its various commissions including delivery to the requirements of NHS England and Office of Life Sciences commissions.
- Success in the Manchester Biomedical Research Centre bid, which has been awarded £59.1m over five years, a significant uplift on the previous settlement.
- Successfully securing a grant from Innovate UK and industry investment for a circa £20m innovation accelerator programme.
- Leading on the design and development of a GM approach for virtual wards, which is now currently delivering >400 virtual beds across the system.
- Grown the use of GM Care Record by around 25% in year to 19,000 users and 190,000 patient consultations per month, and driven academic outputs from the GM Care Record (3 publications, 42 studies in the pipeline overall).
- Led the successful wave 1 NHS England Secure Data Environment bid process for GM and the wider NW region, securing £11m over three years.
- Led on successful bids through 2022/23 to leverage over £100m of investment into the GM system.
We are delighted to publish the Innovation for Healthcare Inequalities Programme (InHIP) impact and learning report. NHS England’s InHIP programme is a collaboration between the Accelerated Access Collaborative (AAC), NHS England’s National Healthcare Inequalities Improvement Programme and the Health Innovation Network, delivered in partnership with integrated care systems (ICSs). It aims to address local healthcare [...]
Download our Impact Report In 2023-24, as a Network, we delivered national programmes and initiatives that benefitted over 1,228,000 patients, created wealth and health by leveraging £467m through our support to innovators, and worked alongside health and care teams to tackle some of the NHS’s most pressing challenges including cardiovascular disease, patient safety and [...]
We are delighted to welcome Dr Dominique Allwood as the new Chief Executive Officer for Imperial College Health Partners (ICHP). Dominique joins ICHP from neighbouring health innovation network UCLPartners, where she is currently Chief Medical Officer. Her focus is on clinical engagement across the partnership and with the Health Innovation Network Clinical Executives in her [...]
